Jacob Denise, Merrill Anna E, Voss Dena R, Bebber Tami, Davis Scott R, Kulhavy Jeff, Krasowski Matthew D
Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA.
Data Brief. 2020 Sep 1;32:106252. doi: 10.1016/j.dib.2020.106252. eCollection 2020 Oct.
Intraoperative monitoring of parathyroid hormone (PTH) is commonly used during parathyroidectomies. There are a number of practical challenges in achieving rapid turnaround time (TAT) for intraoperative PTH testing, whether the testing is performed point-of-care, near point-of-care, or in a central clinical laboratory. In the related research article, we analyzed a decade of data from 3025 intraoperative PTH tests on 897 unique patients. Of these, 1787 tests on 514 unique patients (375 female, 139 male) occurred while intraoperative PTH measurement was done as near point-of-care testing; the remaining 1238 tests on 383 unique patients (282 female, 101 male) occurred after a switch to intraoperative PTH measurement by the hospital central laboratory. The data in this article provides the patient age, gender, location of surgery (main operating rooms vs. ambulatory surgery center), incision to close time for surgery, and operation start to end times. For the central laboratory testing, additional data are provided for the intraoperative PTH TAT. The analyzed data is provided in the supplementary tables included in this article. Plots of operation start and end times are also included. The dataset reported is related to the research article entitled "Evaluation of Switch from Satellite Laboratory to Central Laboratory for Testing of Intraoperative Parathyroid Hormone" [D. Jacob, G. Lal, D.R. Voss, T. Bebber, S.R. David, J. Kulhavy, S.L. Sugg, A.E. Merrill, M.D. Krasowski, Evaluation of Switch from Satellite Laboratory to Central Laboratory for Testing of Intraoperative Parathyroid Hormone, Pract. Lab. Med. (2020) 22: e00176] [1].
甲状旁腺切除术期间通常会进行甲状旁腺激素(PTH)的术中监测。无论术中PTH检测是在床旁、近床旁还是在中心临床实验室进行,要实现快速周转时间(TAT)都存在一些实际挑战。在相关研究文章中,我们分析了来自897例独特患者的3025次术中PTH检测的十年数据。其中,对514例独特患者(375例女性,139例男性)进行的1787次检测是在术中PTH测量作为近床旁检测时进行的;其余对383例独特患者(282例女性,101例男性)进行的1238次检测是在医院中心实验室转为术中PTH测量后进行的。本文中的数据提供了患者年龄、性别、手术地点(主手术室与门诊手术中心)、手术切口至关闭时间以及手术开始至结束时间。对于中心实验室检测,还提供了术中PTH TAT的额外数据。分析的数据在本文包含的补充表中提供。还包括手术开始和结束时间的图表。报告的数据集与题为《从卫星实验室转向中心实验室检测术中甲状旁腺激素的评估》的研究文章相关[D. 雅各布、G. 拉尔、D.R. 沃斯、T. 贝伯、S.R. 大卫、J. 库尔哈维、S.L. 萨格、A.E. 梅里尔、M.D. 克拉索夫斯基,《从卫星实验室转向中心实验室检测术中甲状旁腺激素的评估》,《实用实验室医学》(2020年)22卷:e00176][1]。